Beyond designer babies: What’s the future of ‘bio-modifications’?

Biohackers LED

Vanderbilt University professor Michael Bess’s presentation, “Our Grandchildren Redesigned,” was presented at the Dawn or Doom conference on [September 27]. Bess described a future where a person’s status and worth are defined by their modified capabilities. He envisions a world where products that enhance human intelligence, communication, physical ability and talents are constantly offering new upgrades, turning bio-modifications into the new normal.

With the introduction of more potent, precise drugs, the average life and health span of individuals will increase, and aging will be slowed down, if not reversed. On the other hand, the enhanced physical and mental performance of some individuals over others will, Bess believes, also result in the division of groups based on performance.

Advancements in the field of bioelectronics offer life-altering treatments to individuals with physical impairments.

ADVERTISEMENT

Bess also believes that creating designer babies using genetic modification is a method that will be abandoned in favor of epigenetics.

Traditional genetic modification selects what genes will exist in an individual’s body. In contrast, when using epigenetics, a person’s DNA remains constant but some traits are turned on and used while others are programmed to stay dormant…

Bess said that with epigenetics “you can tweak, adjust, boost and upgrade at will.”

ADVERTISEMENT
ADVERTISEMENT

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Talk explores future of genetic manipulation

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend